SCHEMBL6724709

SCHEMBL6724709

CCCOC(Cc1cccc2c1ccn2CCO)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 6/20 0.46
PPARG P37231 5/20 0.46
PPARD Q03181 4/20 0.46
CREBBP Q92793 1/20 0.37
NR5A1 Q13285 3/20 0.34
MCL1 Q07820 2/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34
TUBB6 Q9BUF5 1/20 0.34
TUBB2B Q9BVA1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4340097 0.86 PPARG (0.45) PPARAPPARGPPARDCREBBPNR5A1
SCHEMBL6727371 0.86 CREBBP (0.45) PPARAPPARGPPARDCREBBPMCL1
SCHEMBL6727386 0.75 ALDH1A1 (0.48) MCL1MAPTLMNAKDM4EALDH1A1
SCHEMBL6724782 0.74 CYP4F2 (0.49) PPARAPPARGLMNAALDH1A1TSHR
SCHEMBL4334672 0.72 CREBBP (0.48) CREBBPMCL1MAPTLMNAALDH1A1
SCHEMBL5017298 0.72 PPARG (0.81) PPARAPPARGPPARD
SCHEMBL6723558 0.70 ALDH1A1 (0.37) PPARAPPARGLMNAALDH1A1TSHR
SCHEMBL5015817 0.70 PPARG (0.89) PPARAPPARGPPARD
SCHEMBL6731797 0.69 CYP4F2 (0.51) PPARAPPARGPPARDLMNA
SCHEMBL5017281 0.69 PPARG (0.89) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 PPARA 339/4885PPARG 379/4885PPARD 753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.